N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide

C155H169N33O12 — CID 158044380

IUPACN-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
SMILESCCc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.CN1CCN(c2ccnc(CNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)c2)CC1.Cc1ccccc1-c1cccc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccncc1-c1ccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cc1.Cn1cc(-c2ccc(CCNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)cc2)cn1.Cn1cc(-c2cccc(CCNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)c2)cn1
InChIInChI=1S/C28H29N5O2.C28H28N4O2.2C26H28N6O2.C25H31N7O2.C22H25N5O2/c1-19-8-12-29-18-24(19)21-4-2-20(3-5-21)9-13-30-28(34)25-7-6-22-17-31-27(16-26(22)33-25)32-23-10-14-35-15-11-23;1-19-5-2-3-8-24(19)21-7-4-6-20(15-21)17-30-28(33)25-10-9-22-18-29-27(16-26(22)32-25)31-23-11-13-34-14-12-23;1-32-17-21(16-29-32)19-4-2-18(3-5-19)8-11-27-26(33)23-7-6-20-15-28-25(14-24(20)31-23)30-22-9-12-34-13-10-22;1-32-17-21(16-29-32)19-4-2-3-18(13-19)7-10-27-26(33)23-6-5-20-15-28-25(14-24(20)31-23)30-22-8-11-34-12-9-22;1-31-8-10-32(11-9-31)21-4-7-26-20(14-21)17-28-25(33)22-3-2-18-16-27-24(15-23(18)30-22)29-19-5-12-34-13-6-19;1-2-15-5-8-23-18(11-15)14-25-22(28)19-4-3-16-13-24-21(12-20(16)27-19)26-17-6-9-29-10-7-17/h2-8,12,16-18,23H,9-11,13-15H2,1H3,(H,30,34)(H,31,32);2-10,15-16,18,23H,11-14,17H2,1H3,(H,29,31)(H,30,33);2-7,14-17,22H,8-13H2,1H3,(H,27,33)(H,28,30);2-6,13-17,22H,7-12H2,1H3,(H,27,33)(H,28,30);2-4,7,14-16,19H,5-6,8-13,17H2,1H3,(H,27,29)(H,28,33);3-5,8,11-13,17H,2,6-7,9-10,14H2,1H3,(H,24,26)(H,25,28)
InChIKeyFISOKDZAUSMFCO-UHFFFAOYSA-N
MW2686.28 g/mol
LogP22.28
Rot. Bonds39

About N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide

N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide (PubChem CID 158044380) has the molecular formula C155H169N33O12 and a molecular weight of 2686.28 g/mol. Its IUPAC name is N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide.

Molecular Properties

Compound NameN-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
PubChem CID158044380
Molecular FormulaC155H169N33O12
Molecular Weight2686.28 g/mol
Exact Mass2684.36
IUPAC NameN-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
SMILESCCc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.CN1CCN(c2ccnc(CNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)c2)CC1.Cc1ccccc1-c1cccc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccncc1-c1ccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cc1.Cn1cc(-c2ccc(CCNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)cc2)cn1.Cn1cc(-c2cccc(CCNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)c2)cn1
InChIInChI=1S/C28H29N5O2.C28H28N4O2.2C26H28N6O2.C25H31N7O2.C22H25N5O2/c1-19-8-12-29-18-24(19)21-4-2-20(3-5-21)9-13-30-28(34)25-7-6-22-17-31-27(16-26(22)33-25)32-23-10-14-35-15-11-23;1-19-5-2-3-8-24(19)21-7-4-6-20(15-21)17-30-28(33)25-10-9-22-18-29-27(16-26(22)32-25)31-23-11-13-34-14-12-23;1-32-17-21(16-29-32)19-4-2-18(3-5-19)8-11-27-26(33)23-7-6-20-15-28-25(14-24(20)31-23)30-22-9-12-34-13-10-22;1-32-17-21(16-29-32)19-4-2-3-18(13-19)7-10-27-26(33)23-6-5-20-15-28-25(14-24(20)31-23)30-22-8-11-34-12-9-22;1-31-8-10-32(11-9-31)21-4-7-26-20(14-21)17-28-25(33)22-3-2-18-16-27-24(15-23(18)30-22)29-19-5-12-34-13-6-19;1-2-15-5-8-23-18(11-15)14-25-22(28)19-4-3-16-13-24-21(12-20(16)27-19)26-17-6-9-29-10-7-17/h2-8,12,16-18,23H,9-11,13-15H2,1H3,(H,30,34)(H,31,32);2-10,15-16,18,23H,11-14,17H2,1H3,(H,29,31)(H,30,33);2-7,14-17,22H,8-13H2,1H3,(H,27,33)(H,28,30);2-6,13-17,22H,7-12H2,1H3,(H,27,33)(H,28,30);2-4,7,14-16,19H,5-6,8-13,17H2,1H3,(H,27,29)(H,28,33);3-5,8,11-13,17H,2,6-7,9-10,14H2,1H3,(H,24,26)(H,25,28)
InChIKeyFISOKDZAUSMFCO-UHFFFAOYSA-N
XLogP22.28
TPSA537.63 Ų
H-Bond Donors12
H-Bond Acceptors39
Rotatable Bonds39
Heavy Atoms200
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002686.28
LogP ≤ 522.28
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1039

Analyze N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(5-Amino-8-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)-1,6-naphthyridin-2-yl)(piperazin-1-yl)methanone
CID 118660710
[5-Amino-8-[4-(1-methylpyrazol-4-yl)phenyl]-1,6-naphthyridin-2-yl]-morpholin-4-ylmethanone
CID 118660788
2-Tert-butyl-1'-[1-(propan-2-ylamino)isoquinoline-7-carbonyl]spiro[4,6-dihydropyrazolo[3,4-c]pyridine-5,4'-piperidine]-7-one
CID 91928575
2-Tert-butyl-1'-[1-(2-methoxyethylamino)isoquinoline-7-carbonyl]spiro[4,6-dihydropyrazolo[3,4-c]pyridine-5,4'-piperidine]-7-one
CID 91928579
1-benzoyl-N-[6-[1-methyl-5-(piperidin-1-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]piperidine-4-carboxamide
CID 132056290
N-[6-[1-methyl-5-(morpholin-4-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]-2-morpholin-4-ylpyridine-4-carboxamide
CID 132056739
N-[6-[1-methyl-5-(piperidin-1-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]-3-(pyrrolidin-1-ylmethyl)benzamide
CID 132057272
US11247989, Example 92
CID 132186511
N-[(4,6-Dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-[6-[4-[2-[3-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]propanoylamino]ethyl]piperazin-1-yl]pyridin-3-yl]-1-propan-2-ylindazole-4-carboxamide
CID 139413605
2-N-methyl-5-N-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]pyridine-2,5-dicarboxamide
CID 132056726
N-[6-[1-methyl-5-(piperidin-1-ylmethyl)pyrazol-4-yl]isoquinolin-3-yl]-2-morpholin-4-ylpyridine-4-carboxamide
CID 132056841
5-[8-[5-acetyl-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-3-yl]isoquinolin-3-yl]-N-[1-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]piperidin-4-yl]pyridine-2-carboxamide
CID 168475955

Frequently Asked Questions

What is the IUPAC name of N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The IUPAC name of N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide (CID 158044380) is N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide.
What is the SMILES notation for N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The canonical SMILES for N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide is CCc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.CN1CCN(c2ccnc(CNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)c2)CC1.Cc1ccccc1-c1cccc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccncc1-c1ccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cc1.Cn1cc(-c2ccc(CCNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)cc2)cn1.Cn1cc(-c2cccc(CCNC(=O)c3ccc4cnc(NC5CCOCC5)cc4n3)c2)cn1.
What is the InChIKey of N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The InChIKey is FISOKDZAUSMFCO-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H29N5O2.C28H28N4O2.2C26H28N6O2.C25H31N7O2.C22H25N5O2/c1-19-8-12-29-18-24(19)21-4-2-20(3-5-21)9-13-30-28(34)25-7-6-22-17-31-27(16-26(22)33-25)32-23-10-14-35-15-11-23;1-19-5-2-3-8-24(19)21-7-4-6-20(15-21)17-30-28(33)25-10-9-22-18-29-27(16-26(22)32-25)31-23-11-13-34-14-12-23;1-32-17-21(16-29-32)19-4-2-18(3-5-19)8-11-27-26(33)23-7-6-20-15-28-25(14-24(20)31-23)30-22-9-12-34-13-10-22;1-32-17-21(16-29-32)19-4-2-3-18(13-19)7-10-27-26(33)23-6-5-20-15-28-25(14-24(20)31-23)30-22-8-11-34-12-9-22;1-31-8-10-32(11-9-31)21-4-7-26-20(14-21)17-28-25(33)22-3-2-18-16-27-24(15-23(18)30-22)29-19-5-12-34-13-6-19;1-2-15-5-8-23-18(11-15)14-25-22(28)19-4-3-16-13-24-21(12-20(16)27-19)26-17-6-9-29-10-7-17/h2-8,12,16-18,23H,9-11,13-15H2,1H3,(H,30,34)(H,31,32);2-10,15-16,18,23H,11-14,17H2,1H3,(H,29,31)(H,30,33);2-7,14-17,22H,8-13H2,1H3,(H,27,33)(H,28,30);2-6,13-17,22H,7-12H2,1H3,(H,27,33)(H,28,30);2-4,7,14-16,19H,5-6,8-13,17H2,1H3,(H,27,29)(H,28,33);3-5,8,11-13,17H,2,6-7,9-10,14H2,1H3,(H,24,26)(H,25,28).
What are the key properties of N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide has a molecular weight of 2686.28 g/mol, XLogP of 22.28, 39 rotatable bonds, 12 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-ethyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[3-(2-methylphenyl)phenyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[[4-(4-methylpiperazin-1-yl)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[4-(4-methyl-3-pyridinyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide is sourced from PubChem (CID 158044380), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).